CD151-'3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion

Oncotarget

Volumn 6, Issue 30, 2015, Pages 29675-29693

  Zhou, Pengcheng ^a   Erfani, Sonia ^b   Liu, Zeyi ^b,c   Jia, Changhe ^b,d   Chen, Yecang ^e   Xu, Bingwei ^b   Deng, Xinyu ^b   Alfáro, Jose E ^a   Chen, Li ^b   Napier, Dana ^b   Lu, Michael ^f   Huang, Jian An ^c   Liu, Chunming ^b   Thibault, Olivier ^b   Segal, Rosalind ^a   Zhou, Binhua P ^b   Kyprianou, Natasha ^b   Horbinski, Craig ^b   Yang, Xiuwei H ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c SOOCHOW UNIVERSITY   (China)

^d HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^e UNIVERSITY OF KENTUCKY   (United States)

^f FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

A3 integrin; CD151; Cell invasion and motility; EGFR; Glioblastoma

Indexed keywords

BIOLOGICAL MARKER; CD151 ANTIGEN; FOCAL ADHESION KINASE; ISOCITRATE DEHYDROGENASE 1; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN 26; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VERY LATE ACTIVATION ANTIGEN 3; ARHGAP26 PROTEIN, HUMAN; CD151 PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; FOCAL ADHESION KINASE 1; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; IDH1 PROTEIN, HUMAN; ISOCITRATE DEHYDROGENASE; PTK2 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; CELL INVASION; CELL MOTILITY; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENE MUTATION; GENE SILENCING; GENETIC ASSOCIATION; GLIOBLASTOMA; GLIOMA CELL LINE; HUMAN; HUMAN TISSUE; IDH1 GENE; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MIDDLE AGED; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TISSUE MICROARRAY; UPREGULATION; ANIMAL; CELL MOTION; CELL PROLIFERATION; GENETICS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; METABOLISM; MUTATION; NUDE MOUSE; PATHOLOGY; PROGNOSIS; RNA INTERFERENCE; SURVIVAL ANALYSIS; TUMOR CELL LINE; TUMOR INVASION; XENOGRAFT;

ANIMALS; ANTIGENS, CD151; BIOMARKERS, TUMOR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FOCAL ADHESION KINASE 1; GLIOBLASTOMA; GTPASE-ACTIVATING PROTEINS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA3BETA1; ISOCITRATE DEHYDROGENASE; MICE, NUDE; MUTATION; NEOPLASM INVASIVENESS; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA INTERFERENCE; SURVIVAL ANALYSIS; TISSUE ARRAY ANALYSIS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84945143875     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.4896     Document Type: Article

References (57)

1. Weller M, Pfister SM, Wick W, Hegi ME, Reifenberger G, Stupp R. Molecular neuro-oncology in clinical practice: a new horizon. The lancet oncology. 2013; 14:e370-379.
2. Vehlow A, Cordes N. Invasion as target for therapy of glioblastoma multiforme. Biochimica et biophysica acta. 2013; 1836:236-244.
3. Dunn GP, Rinne ML, Wykosky J, Genovese G, Quayle SN, Dunn IF, Agarwalla PK, Chheda MG, Campos B, Wang A, Brennan C, Ligon KL, Furnari F, Cavenee WK, Depinho RA, Chin L, et al. Emerging insights into the molecular and cellular basis of glioblastoma. Genes & development. 2012; 26:756-784.
4. Francis JM, Zhang CZ, Maire CL, Jung J, Manzo VE, Adalsteinsson VA, Homer H, Haidar S, Blumenstiel B, Pedamallu CS, Ligon AH, Love JC, Meyerson M, Ligon KL. EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencing. Cancer discovery. 2014; 4:956-971.
5. Gini B, Mischel PS. Greater than the sum of its parts: single-nucleus sequencing identifies convergent evolution of independent EGFR mutants in GBM. Cancer discovery. 2014; 4:876-878.
6. Hynes RO. Integrins: Bidirectional, allosteric signaling machines. Cell. 2002; 110:673-687.
7. Nakada M, Nambu E, Furuyama N, Yoshida Y, Takino T, Hayashi Y, Sato H, Sai Y, Tsuji T, Miyamoto KI, Hirao A, Hamada JI. Integrin alpha3 is overexpressed in glioma stem-like cells and promotes invasion. British journal of cancer. 2013; 108:2516-2524.
8. Fukushima Y, Ohnishi T, Arita N, Hayakawa T, Sekiguchi K. Integrin alpha 3 beta 1-mediated interaction with laminin-5 stimulates adhesion, migration and invasion of malignant glioma cells. International Journal of Cancer. 1998; 76:63-72.
9. Kawataki T, Yamane T, Naganuma H, Rousselle P, Anduren I, Tryggvason K, Patarroyo M. Laminin isoforms and their integrin receptors in glioma cell migration and invasiveness: Evidence for a role of alpha 5-laminin(s) and alpha 3 beta 1 integrin. Experimental cell research. 2007; 313:3819-3831.
10. Lathia JD, Gallagher J, Heddleston JM, Wang J, Eyler CE, Macswords J, Wu Q, Vasanji A, McLendon RE, Hjelmeland AB, Rich JN. Integrin alpha 6 regulates glioblastoma stem cells. Cell stem cell. 2010; 6:421-432.
11. Stipp CS. Laminin-binding integrins and their tetraspanin partners as potential antimetastatic targets. Expert Reviews in Molecular Medicine. 2010; :12.
12. Janouskova H, Maglott A, Leger DY, Bossert C, Noulet F, Guerin E, Guenot D, Pinel S, Chastagner P, Plenat F, EntzWerle N, Lehmann-Che J, Godet J, Martin S, Teisinger J, Dontenwill M. Integrin alpha5beta1 plays a critical role in resistance to temozolomide by interfering with the p53 pathway in high-grade glioma. Cancer Res. 2012; 72:3463-3470.
13. Tabatabai G, Tonn JC, Stupp R, Weller M. The role of integrins in glioma biology and anti-glioma therapies. Current pharmaceutical design. 2011; 17:2402-2410.
14. Hemler ME. Targeting of tetraspanin proteins-potential benefits and strategies. Nature Reviews Drug Discovery. 2008; 7:747-758.
15. Deng X, Li Q, Hoff J, Novak M, Yang H, Jin H, Erfani SF, Sharma C, Zhou P, Rabinovitz I, Sonnenberg A, Yi Y, Stipp CS, Kaetzel DM, Hemler ME, Yang XH. IntegrinAssociated CD151 Drives ErbB2-Evoked Mammary Tumor Onset and Metastasis. Neoplasia. 2012; 14:678-689.
16. Yang X, Kovalenko OV, Tang W, Claas C, Stipp CS, Hemler ME. Palmitoylation supports assembly and function of integrin-tetraspanin complexes. Journal of Cell Biology. 2004; 167:1231-1240.
17. Hemler ME. Tetraspanin functions and associated microdomains. Nature Reviews Molecular Cell Biology. 2005; 6:801-811.
18. Kazarov AR, Yang XW, Stipp CS, Sehgal B, Hemler ME. An extracellular site on tetraspanin CD151 determines alpha 3 and alpha 6 integrin-dependent cellular morphology. Journal of Cell Biology. 2002; 158:1299-1309.
19. Rubinstein E. The complexity of tetraspanins. Biochem Soc Trans. 2011; 39:501-505.
20. Yang XH, Mirchev R, Deng X, Yacono P, Yang HL, Golan DE, Hemler ME. CD151 restricts alpha6 integrin diffusion mode. J Cell Sci. 2012.
21. Hemler ME. Tetraspanin proteins promote multiple cancer stages. Nature reviews Cancer. 2014; 14:49-60.
22. Romanska HM, Berditchevski F. Tetraspanins in human epithelial malignancies. Journal of Pathology. 2011; 223:4-14.
23. Budczies J, Klauschen F, Sinn BV, Gyorffy B, Schmitt WD, Darb-Esfahani S, Denkert C. Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization. PloS one. 2012; 7:e51862.
24. Horbinski C. What do we know about IDH1/2 mutations so far, and how do we use it? Acta neuropathologica. 2013; 125:621-636.
25. Kolesnikova TV, Kazarov AR, Lemieux ME, Lafleur MA, Kesari S, Kung AL, Hemler ME. Glioblastoma inhibition by cell surface immunoglobulin protein EWI-2, in vitro and in vivo. Neoplasia. 2009; 11:77-86. 4p following 86.
26. Haynes HR, Camelo-Piragua S, Kurian KM. Prognostic and predictive biomarkers in adult and pediatric gliomas: toward personalized treatment. Frontiers in oncology. 2014; 4:47.
27. Vitucci M, Hayes DN, Miller CR. Gene expression profiling of gliomas: merging genomic and histopathological classification for personalised therapy. British journal of cancer. 2011; 104:545-553.
28. Yang XWH, Richardson AL, Torres-Arzayus MI, Zhou PC, Sharma C, Kazarov AR, Andzelm MM, Strominger JL, Brown M, Hemler ME. CD151 accelerates breast cancer by regulating alpha(6) integrin function, signaling, and molecular organization. Cancer Res. 2008; 68:3204-3213.
29. Yang X, Claas C, Kraeft SK, Chen LB, Wang Z, Kreidberg JA, Hemler ME. Palmitoylation of tetraspanin proteins: modulation of CD151 lateral interactions, subcellular distribution, and integrin-dependent cell morphology. Molecular biology of the cell. 2002; 13:767-781.
30. Yang XH, Flores LM, Li Q, Zhou P, Xu F, Krop IE, Hemler ME. Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes breast cancer cells to ErbB2 antagonists. Cancer Res. 2010; 70:2256-2263.
31. Fortin Ensign SP, Mathews IT, Symons MH, Berens ME, Tran NL. Implications of Rho GTPase Signaling in Glioma Cell Invasion and Tumor Progression. Frontiers in oncology. 2013; 3:241.
32. Choma DP, Pumiglia K, DiPersio CM. Integrin alpha 3 beta 1 directs the stabilization of a polarized lamellipodium in epithelial cells through activation of Rac1. J Cell Sci. 2004; 117:3947-3959.
33. Jarzynka MJ, Hu B, Hui KM, Bar-Joseph I, Gu W, Hirose T, Haney LB, Ravichandran KS, Nishikawa R, Cheng SY. ELMO1 and Dock180, a bipartite Rac1 guanine nucleotide exchange factor, promote human glioma cell invasion. Cancer Res. 2007; 67:7203-7211.
34. Lee D, Suh YL, Park TI, Do IG, Seol HJ, Nam DH, Kim ST. Prognostic significance of tetraspanin CD151 in newly diagnosed glioblastomas. Journal of surgical oncology. 2013; 107:646-652.
35. Ha SY, Kang SY, Do IG, Suh YL. Glioblastoma with oligodendroglial component represents a subgroup of glioblastoma with high prevalence of IDH1 mutation and association with younger age. Journal of neuro-oncology. 2013; 112:439-448.
36. Han ZB, Yang Z, Chi Y, Zhang L, Wang Y, Ji Y, Wang J, Zhao H, Han ZC. MicroRNA-124 suppresses breast cancer cell growth and motility by targeting CD151. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology. 2013; 31:823-832.
37. Sturm D, Bender S, Jones DT, Lichter P, Grill J, Becher O, Hawkins C, Majewski J, Jones C, Costello JF, Iavarone A, Aldape K, Brennan CW, Jabado N, Pfister SM. Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge. Nature reviews Cancer. 2014; 14:92-107.
38. Martin S, Janouskova H, Dontenwill M. Integrins and p53 pathways in glioblastoma resistance to temozolomide. Frontiers in oncology. 2012; 2:157.
39. Kohno M, Hasegawa H, Miyake M, Yamamoto T, Fujita S. CD151 enhances cell motility and metastasis of cancer cells in the presence of focal adhesion kinase. International Journal of Cancer. 2002; 97:336-343.
40. Ljubimova JY, Lakhter AJ, Loksh A, Yong WH, Riedinger MS, Miner JH, Sorokin LM, Ljubimov AV, Black KL. Overexpression of alpha 4 chain-containing laminins in human glial tumors identified by gene microarray analysis. Cancer Res. 2001; 61:5601-5610.
41. Zhou B, Gibson-Corley KN, Herndon ME, Sun Y, Gustafson-Wagner E, Teoh-Fitzgerald M, Domann FE, Henry MD, Stipp CS. Integrin alpha3beta1 can function to promote spontaneous metastasis and lung colonization of invasive breast carcinoma. Molecular cancer research: MCR. 2014; 12:143-154.
42. Durbeej M. Laminins. Cell and tissue research. 2010; 339:259-268.
43. Rajasekhar VK, Studer L, Gerald W, Socci ND, Scher HI. Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-kappaB signalling. Nat Commun. 2011; 2:162.
44. Yin Y, Deng X, Liu Z, Baldwin LA, Lefringhouse J, Zhang J, Hoff JT, Erfani SF, Rucker EB 3rd, O'Connor K, Liu C, Wu Y, Zhou BP, Yang XH. CD151 represses mammary gland development by maintaining the niches of progenitor cells. Cell Cycle. 2014; 13:2707-2722.
45. Natarajan M, Stewart JE, Golemis EA, Pugacheva EN, Alexandropoulos K, Cox BD, Wang W, Grammer JR, Gladson CL. HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells. Oncogene. 2006; 25:1721-1732.
46. Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, Damsky CH, Schlaepfer DD. FAK integrates growth-factor and integrin signals to promote cell migration. Nature cell biology. 2000; 2:249-256.
47. Flinder LI, Timofeeva OA, Rosseland CM, Wierod L, Huitfeldt HS, Skarpen E. EGF-induced ERK-activation downstream of FAK requires rac1-NADPH oxidase. Journal of cellular physiology. 2011; 226:2267-2278.
48. Simpson KJ, Selfors LM, Bui J, Reynolds A, Leake D, Khvorova A, Brugge JS. Identification of genes that regulate epithelial cell migration using an siRNA screening approach. Nature cell biology. 2008; 10:1027-1038.
49. Franco M, Muratori C, Corso S, Tenaglia E, Bertotti A, Capparuccia L, Trusolino L, Comoglio PM, Tamagnone L. The tetraspanin CD151 is required for Met-dependent signaling and tumor cell growth. J Biol Chem. 2010; 285:38756-38764.
50. Bredel M, Bredel C, Juric D, Harsh GR, Vogel H, Recht LD, Sikic BI. Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas. Cancer Res. 2005; 65:8679-8689.
51. Chen J, McKay RM, Parada LF. Malignant glioma: lessons from genomics, mouse models, and stem cells. Cell. 2012; 149:36-47.
52. Yang XH, Richardson AL, Torres-Arzayus MI, Zhou P, Sharma C, Kazarov AR, Andzelm MM, Strominger JL, Brown M, Hemler ME. CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization. Cancer Res. 2008; 68:3204-3213.
53. Zijlstra A, Lewis J, Degryse B, Stuhlmann H, Quigley JP. The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151. Cancer cell. 2008; 13:221-234.
54. Baldwin LA, Hoff JT, Lefringhouse J, Zhang M, Jia C, Liu Z, Erfani S, Jin H, Xu M, She QB, van Nagell JR, Wang C, Chen L, Plattner R, Kaetzel DM, Luo J, et al. CD151-alpha3beta1 integrin complexes suppress ovarian tumor growth by repressing slug-mediated EMT and canonical Wnt signaling. Oncotarget. 2014;5:12203-12217.
55. Varzavand A, Drake JM, Svensson RU, Herndon ME, Zhou B, Henry MD, Stipp CS. Integrin alpha3beta1 regulates tumor cell responses to stromal cells and can function to suppress prostate cancer metastatic colonization. Clinical & experimental metastasis. 2013; 30:541-552.
56. Redjal N, Chan JA, Segal RA, Kung AL. CXCR4 inhibition synergizes with cytotoxic chemotherapy in gliomas. Clinical cancer research: an official journal of the American Association for Cancer Research. 2006; 12:6765-6771.
57. Rubin JB, Kung AL, Klein RS, Chan JA, Sun Y, Schmidt K, Kieran MW, Luster AD, Segal RA. A smallmolecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proceedings of the National Academy of Sciences of the United States of America. 2003; 100:13513-13518.